Disability Levels and Cognitive Functioning Reported by Patients Impaired by Gentamicin and Other Aminoglycosides
The purpose of this study was to explore disability levels and cognitive functioning in patients who reported being damaged by aminoglycosides, a class of antibiotic drugs. An online questionnaire was published using the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) and t...
Main Author: | Ann M. Kerlin |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-05-01
|
Series: | SAGE Open |
Online Access: | https://doi.org/10.1177/2158244017709323 |
Similar Items
-
Extended-Interval Aminoglycoside (EIA) Regimen – Focus on Gentamicin and Amikacin
by: Lily Li-Chun Lai, et al.
Published: (2004) -
PHARMACOKINETICS AND PHARMACODYNAMICS OF ANTIMICROBIAL AGENTS IN PATIENTS WITH IMPAIRED RENAL FUNCTION: AMINOGLYCOSIDES
by: M. Kolesnyk, et al.
Published: (2017-12-01) -
Kinetics of kill of bacterial conjunctivitis isolates with moxifloxacin, a fluoroquinolone, compared with the aminoglycosides tobramycin and gentamicin
by: Rudolph S Wagner, et al.
Published: (2010-01-01) -
Aminoglycosides and kidney function
by: Stanić Momčilo, et al.
Published: (2007-01-01) -
Aminoglycoside trough levels in neonates
by: Pejović Biljana, et al.
Published: (2010-01-01)